Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Markets Fall To Conclude Holiday-Shortened Week Of Trading

U.S. indices fell Thursday to conclude the holiday-shortened week of trading amid continued concerns over Fed tapering in order to combat inflation. Investors also reacted to earnings from notable banks including Wells Fargo, Citigroup and Goldman Sachs.

Benzinga

Biomerica: Q3 Earnings Insights

Biomerica (NASDAQ:BMRA) reported its Q3 earnings results on Thursday, April 14, 2022 at 08:31 AM. Here's what investors need to know about the announcement. Earnings Biomerica beat estimated earnings by 90.0%, reporting an EPS of $-0.01 versus an estimate of $-0.1.

Benzinga

Recap: AstroNova Q4 Earnings

AstroNova (NASDAQ:ALOT) reported its Q4 earnings results on Thursday, April 14, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings AstroNova missed estimated earnings by 1100.0%, reporting an EPS of $-0.1 versus an estimate of $0.01.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Manhattan Bridge Capital: Q1 Earnings Insights

Manhattan Bridge Capital (NASDAQ:LOAN) reported its Q1 earnings results on Thursday, April 14, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Manhattan Bridge Capital reported in-line EPS of $0.12 versus an estimate of $0.12.

Benzinga

Death Cross Looms Over Marvell Tech Investors

If history is any guide, there may be trouble ahead for shares of Marvell Tech (NASDAQ:MRVL). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Earnings Preview: Zovio

Zovio (NASDAQ:ZVO) is set to give its latest quarterly earnings report on Friday, 2022-04-15. Here's what investors need to know before the announcement. Analysts estimate that Zovio will report an earnings per share (EPS) of $-0.11.

Benzinga

Expert Ratings for Apellis Pharmaceuticals

Over the past 3 months, 4 analysts have published their opinion on Apellis Pharmaceuticals (NASDAQ:APLS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

If You Invested $1000 In Mullen Automotive 5 Years Ago, Here's How Much You Would Have Today

Mullen Automotive (NASDAQ:MULN) has outperformed the market over the past 5 years by 7.25% on an annualized basis producing an average annual return of 20.68%. Currently, Mullen Automotive has a market capitalization of $516.88 million.

Benzinga

Marijuana Stock Movers For April 14, 2022

GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 50.00% at $0.02

Benzinga

Psychedelic Stock Gainers And Losers From April 14, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 2.50% at $5.32

Benzinga

Elon Musk's Latest Bid For Twitter Takeover

Elon Musk is the richest man in the world; he has Tesla Inc (NASDAQ: TSLA), Neuralink, SpaceX, and now, potentially, Twitter Inc (NYSE: TWTR), too.

Benzinga

BeyondSpring: Q4 Earnings Insights

BeyondSpring (NASDAQ:BYSI) reported its Q4 earnings results on Thursday, April 14, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings BeyondSpring beat estimated earnings by 7.69%, reporting an EPS of $-0.24 versus an estimate of $-0.26.

Benzinga

Unity Bancorp: Q1 Earnings Insights

Unity Bancorp (NASDAQ:UNTY) reported its Q1 earnings results on Thursday, April 14, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Unity Bancorp beat estimated earnings by 4.94%, reporting an EPS of $0.85 versus an estimate of $0.81.

Benzinga

Recap: Telefonaktiebolaget L M Q1 Earnings

Telefonaktiebolaget L M (NASDAQ:ERIC) reported its Q1 earnings results on Thursday, April 14, 2022 at 02:00 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Can Apple Overcome Weak Demand For iPhone SE And Supply Disruptions For Its Other Products?

As some parts of China went into lockdowns, Apple Inc.'s (NASDAQ: AAPL) supply chain partners had to shutter operations. This has engendered fears regarding whether the tech giant can produce enough to meet surging demand for its hardware products.

Benzinga

Marine Petroleum Trust Shares Are Surging: What's Going On?

Marine Petroleum Trust (NASDAQ: MARPS) shares are trading higher Thursday on continued volatility. The nano-cap energy stock has surged amid strength in oil prices in recent months, but it has been trending lower in recent weeks.

Benzinga

SoFi Technologies Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on SoFi Technologies. Looking at options history for SoFi Technologies (NASDAQ:SOFI) we detected 19 strange trades.

Benzinga

If You Invested $1000 In Google 5 Years Ago, Here's How Much You Would Have Today

Alphabet (NASDAQ:GOOGL) has outperformed the market over the past 5 years by 10.95% on an annualized basis producing an average annual return of 24.38%. Currently, Alphabet has a market capitalization of $1.68 trillion.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Raymond James Thinks Med Tech Investors are Somewhat 'Paralyzed' Ahead Of Q1 Earnings

Raymond James has outlined its expectations for next week when Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), and Intuitive Surgical Inc (NASDAQ:ISRG) will report Q1 FY22 earnings. Analysts believe that the Med Tech investors have become somewhat 'paralyzed' given the macro/factor-driven concerns. On the macro, investor attention seems to be focused less on revenue growth and more…

Benzinga

BofA Downgrades Pactiv Evergreen, O-I Glass - Read Why

BofA analyst George Staphos downgraded Pactiv Evergreen Inc (NASDAQ:PTVE) to Neutral from Buy with a price target of $13 (29.6% upside). The analyst also downgraded O-I Glass Inc (NYSE:OI) to Neutral from Buy with a price target of $14 (7% upside). Staphos foresees a chance for macroeconomic trends to decelerate. He lowered his ratings on both the companies as…

Benzinga

What Are Whales Doing With Moderna

Someone with a lot of money to spend has taken a bullish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Where Enphase Energy Stands With Analysts

Analysts have provided the following ratings for Enphase Energy (NASDAQ:ENPH) within the last quarter:

Benzinga

Expert Ratings for Seagate Tech Hldgs

Seagate Tech Hldgs (NASDAQ:STX) has observed the following analyst ratings within the last quarter:

Benzinga

Peering Into Biofrontera Inc. - Common Stock's Recent Short Interest

Biofrontera Inc. - Common Stock's (NASDAQ:BFRI) short percent of float has risen 6.56% since its last report. The company recently reported that it has 821.90 thousand shares sold short, which is 15.93% of all regular shares that are available for trading.

Benzinga

Analyzing Amgen Inc's Short Interest

Amgen Inc's (NASDAQ:AMGN) short percent of float has fallen 8.14% since its last report. The company recently reported that it has 24.47 million shares sold short, which is 4.4% of all regular shares that are available for trading.

1 … 748 749 750 751

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.